<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Serr I</submitter><funding>Kompetenznetz Diabetes mellitus</funding><funding>German Center for Diabetes Research</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>Juvenile Diabetes Research Foundation</funding><funding>National Research Foundation of Korea</funding><funding>National Institutes of Health</funding><funding>Clinical Research Unit 257 CEDER</funding><funding>German Federal Ministry of Education and Research</funding><pagination>eaag1782</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5828501</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(422)</volume><pubmed_abstract>Molecular checkpoints that trigger the onset of islet autoimmunity or progression to human type 1 diabetes (T1D) are incompletely understood. Using T cells from children at an early stage of islet autoimmunity without clinical T1D, we find that a microRNA181a (miRNA181a)-mediated increase in signal strength of stimulation and costimulation links nuclear factor of activated T cells 5 (NFAT5) with impaired tolerance induction and autoimmune activation. We show that enhancing miRNA181a activity increases NFAT5 expression while inhibiting FOXP3+ regulatory T cell (Treg) induction in vitro. Accordingly, Treg induction is improved using T cells from NFAT5 knockout (NFAT5ko) animals, whereas altering miRNA181a activity does not affect Treg induction in NFAT5ko T cells. Moreover, high costimulator</pubmed_abstract><journal>Science translational medicine</journal><pubmed_title>A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes.</pubmed_title><pmcid>PMC5828501</pmcid><funding_grant_id>award309930</funding_grant_id><funding_grant_id>JDRF 17-2012-16</funding_grant_id><funding_grant_id>JDRF 2-SRA-2014-161-Q-R</funding_grant_id><funding_grant_id>award309935</funding_grant_id><funding_grant_id>award309924</funding_grant_id><funding_grant_id>award309936</funding_grant_id><funding_grant_id>award309937</funding_grant_id><funding_grant_id>UC4DK112217</funding_grant_id><funding_grant_id>award309938</funding_grant_id><funding_grant_id>award309931</funding_grant_id><funding_grant_id>award309932</funding_grant_id><funding_grant_id>award309933</funding_grant_id><funding_grant_id>2015R1A3A2032927</funding_grant_id><funding_grant_id>award309923</funding_grant_id><funding_grant_id>award309934</funding_grant_id><funding_grant_id>FKZ 01GI0805-07</funding_grant_id><funding_grant_id>WE 4656/2</funding_grant_id><funding_grant_id>award309929</funding_grant_id><funding_grant_id>JDRF 6-2012-20</funding_grant_id><funding_grant_id>FKZ 01GI0805</funding_grant_id><funding_grant_id>CRC1054 B11</funding_grant_id><funding_grant_id>CRC1811 B02</funding_grant_id><pubmed_authors>Kuper C</pubmed_authors><pubmed_authors>Becker M</pubmed_authors><pubmed_authors>Loretz B</pubmed_authors><pubmed_authors>Waisman A</pubmed_authors><pubmed_authors>Scherm MG</pubmed_authors><pubmed_authors>Flynn VK</pubmed_authors><pubmed_authors>Spornraft M</pubmed_authors><pubmed_authors>Haase B</pubmed_authors><pubmed_authors>Gerlach K</pubmed_authors><pubmed_authors>Segars J</pubmed_authors><pubmed_authors>Kalin S</pubmed_authors><pubmed_authors>Hippich M</pubmed_authors><pubmed_authors>Kaestner KH</pubmed_authors><pubmed_authors>Ziegler AG</pubmed_authors><pubmed_authors>Palmisano R</pubmed_authors><pubmed_authors>Kim WU</pubmed_authors><pubmed_authors>Daniel C</pubmed_authors><pubmed_authors>Kirchner B</pubmed_authors><pubmed_authors>Zahm AM</pubmed_authors><pubmed_authors>Lehr CM</pubmed_authors><pubmed_authors>Achenbach P</pubmed_authors><pubmed_authors>Schug J</pubmed_authors><pubmed_authors>Nikolaev A</pubmed_authors><pubmed_authors>Liebsch N</pubmed_authors><pubmed_authors>Willis RA</pubmed_authors><pubmed_authors>Serr I</pubmed_authors><pubmed_authors>Weigmann B</pubmed_authors></additional><is_claimable>false</is_claimable><name>A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes.</name><description>Molecular checkpoints that trigger the onset of islet autoimmunity or progression to human type 1 diabetes (T1D) are incompletely understood. Using T cells from children at an early stage of islet autoimmunity without clinical T1D, we find that a microRNA181a (miRNA181a)-mediated increase in signal strength of stimulation and costimulation links nuclear factor of activated T cells 5 (NFAT5) with impaired tolerance induction and autoimmune activation. We show that enhancing miRNA181a activity increases NFAT5 expression while inhibiting FOXP3+ regulatory T cell (Treg) induction in vitro. Accordingly, Treg induction is improved using T cells from NFAT5 knockout (NFAT5ko) animals, whereas altering miRNA181a activity does not affect Treg induction in NFAT5ko T cells. Moreover, high costimulator</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jan</publication><modification>2025-04-18T23:20:30.534Z</modification><creation>2019-03-26T23:04:02Z</creation></dates><accession>S-EPMC5828501</accession><cross_references><pubmed>29298866</pubmed><doi>10.1126/scitranslmed.aag1782</doi></cross_references></HashMap>